NewsManipal Health Enterprises IPO Day 1: Subscription status, review — here's what you need to knowManipal Health Enterprises IPO Day 1: Subscription status, review — here's what you need to know
Manipal Health Enterprises IPO is open for subscription with a price band of ₹560-₹590. Day 1 data shows total subscription at 0.12x. QIBs are at 0.12x, Employees at 0.74x, and Retail at 0.19x. The minimum bid quantity is 25 shares.
*this image is generated using AI for illustrative purposes only.
Manipal Health Enterprises IPO opened for subscription today. On the first day of bidding, the issue has been subscribed 0.12 times so far. Retail investors showed the highest interest among categories at 0.19x, while Qualified Institutional Buyers (QIB) subscribed 0.12x.
Subscription Status
The following table details the Day 1 subscription numbers across different investor categories:
| Category | Subscription Multiple |
|---|---|
| Qualified Institutional Buyers (QIB) | 0.12 x |
| Non-Institutional Buyers (bHNI) | 0.06 x |
| Non-Institutional Buyers (sHNI) | 0.06 x |
| Employees | 0.74 x |
| Retail | 0.19 x |
| Total Subscribed | 0.12 x |
About the Company
Manipal Health Enterprises is a key player in the healthcare sector. The company’s IPO aims to raise capital through a fresh issue and/or offer for sale. Investors are closely watching the subscription trends as the bidding window remains open.
Offer Details
Here are the key details of the Manipal Health Enterprises IPO:
- Price Band: ₹560 - ₹590
- Issue Size: ₹14,000 - ₹5,00,000
- Minimum Bid Quantity: 25 shares
- IPO Stage: Day 1 Open
How might the weak Day 1 subscription impact the final listing price and potential premium or discount at listing?
What strategies could the book-running lead managers employ to attract more QIB and NII interest in the remaining bidding days?
Will the healthcare sector's current valuation trends influence investor sentiment towards Manipal Health Enterprises as the IPO window closes?
20
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
